Effect of methylglyoxal on the physico-chemical and biological properties of low-density lipoprotein.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Biochimica et Biophysica Acta

• Publication date

  1998-11-02

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0005-2760(98)00112-XPMID 9795211
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Selective Induction of Heparin-binding Epidermal Growth Factor-like Growth Factor by Methylglyoxal and 3-Deoxyglucosone in Rat Aortic Smooth Muscle Cells

  1997cited by this paper
• Synthesis and secretion of tumour necrosis factor-alpha by human monocytic THP-1 cells and chemotaxis induced by human serum albumin derivatives modified with methylglyoxal and glucose-derived advanced glycation endproducts.

  1997cited by this paper
• N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins.

  1997cited by this paper
• Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxification--a role in pathogenesis and antiproliferative chemotherapy.

  1996cited by this paper
• Induction of synthesis and secretion of interleukin 1 beta in the human monocytic THP-1 cells by human serum albumins modified with methylglyoxal and advanced glycation endproducts.

  1996cited by this paper
• Angiotensin II-modified LDL is taken up by macrophages via the scavenger receptor, leading to cellular cholesterol accumulation.

  1996cited by this paper
• Atherogenic Modified LDL in Diabetes

  1996cited by this paper
• Amino acid analysis by reverse-phase high-performance liquid chromatography: improved derivatization and detection conditions with 9-fluorenylmethyl chloroformate.

  1996cited by this paper
• Protein Cross-linking by the Maillard Reaction

  1996cited by this paper
• Hydroxyalkenal Formation Induced by Advanced Glycosylation of Low Density Lipoprotein (*)

  1996cited by this paper
• Synthesis and secretion of macrophage colony stimulating factor by mature human monocytes and human monocytic THP-1 cells induced by human serum albumin derivatives modified with methylglyoxal and glucose-derived advanced glycation endproducts.

  1996cited by this paper
• Supplementation with low doses of vitamin E protects LDL from lipid peroxidation in men and women.

  1995cited by this paper
• Mechanism of Protein Modification by Glyoxal and Glycolaldehyde, Reactive Intermediates of the Maillard Reaction (*)

  1995cited by this paper
• Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose.

  1995cited by this paper
• Free Radicals Generated during the Glycation Reaction of Amino Acids by Methylglyoxal

  1995cited by this paper
• Spectral Characterization and Chemical Modification of Catalase-Peroxidase from Streptomyces sp. (*)

  1995cited by this paper
• Molecular characteristics of methylglyoxal-modified bovine and human serum albumins. Comparison with glucose-derived advanced glycation endproduct-modified serum albumins

  1995cited by this paper
• Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications.

  1994cited by this paper
• Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency.

  1994cited by this paper
• Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with N alpha-acetylarginine, N alpha-acetylcysteine, and N alpha-acetyllysine, and bovine serum albumin.

  1994cited by this paper
• Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging.

  1994cited by this paper
• Receptor-mediated endocytic uptake of methylglyoxal-modified serum albumin. Competition with advanced glycation end product-modified serum albumin at the advanced glycation end product receptor.

  1994cited by this paper
• Increase in 3-deoxyglucosone levels in diabetic rat plasma. Specific in vivo determination of intermediate in advanced Maillard reaction.

  1994cited by this paper
• The formation of methylglyoxal from triose phosphates

  1993cited by this paper
• The formation of methylglyoxal from triose phosphates. Investigation using a specific assay for methylglyoxal.

  1993cited by this paper
• Lipid advanced glycosylation: pathway for lipid oxidation in vivo.

  1993cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Synthesis and chromatography of 1,2-diamino-4,5-dimethoxybenzene, 6,7-dimethoxy-2-methylquinoxaline and 6,7-dimethoxy-2,3-dimethylquinoxaline for use in a liquid chromatographic fluorimetric assay of methylglyoxal

  1992cited by this paper
• The assay of methylglyoxal in biological systems by derivatization with 1,2-diamino-4,5-dimethoxybenzene.

  1992cited by this paper
• Induction of interleukin-1 production by ligands binding to the scavenger receptor in human monocytes and the THP-1 cell line.

  1991cited by this paper
• Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells.

  1990cited by this paper
• O2- generation and lipid peroxidation during the oxidation of a glycated polypeptide, glycated polylysine, in the presence of iron-ADP.

  1990cited by this paper
• Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells.

  1990cited by this paper
• Glycosylation of Low-Density Lipoprotein Enhances Cholesteryl Ester Synthesis in Human Monocyte-Derived Macrophages

  1988cited by this paper
• Production of Plasminogen Activators and Inhibitor by Serially Propagated Endothelial Cells from Adult Human Blood Vessels

  1987cited by this paper
• Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes.

  1987cited by this paper
• Decrease in Reactive Amino Groups during Oxidation or Endothelial Cell Modification of LDL: Correlation with Changes in Receptor‐Mediated Cataboiism

  1987cited by this paper
• Monosaccharide autoxidation in health and disease.

  1985cited by this paper
• Interaction of low density lipoproteins with arterial proteoglycans. The role of charge and sialic acid content.

  1985cited by this paper
• Glucosylation of Low-Density Lipoproteins to an Extent Comparable to That Seen in Diabetes Slows Their Catabolism

  1984cited by this paper
• Low Density Lipoprotein Metabolism by Endothelial Cells from Human Umbilical Cord Arteries and Veins

  1983cited by this paper
• Nonenzymatic Glucosylation of Low-Density Lipoprotein Alters Its Biologic Activity

  1982cited by this paper
• Specificity of receptor-mediated recognition of malondialdehyde-modified low density lipoproteins.

  1982cited by this paper
• Non‐enzymatic glycosylation of human serum lipoproteins Elevated ϵ‐lysine glycosylated low density lipoprotein in diabetic patients

  1981cited by this paper
• The scavenger cell pathway for lipoprotein degradation: specificity of the binding site that mediates the uptake of negatively-charged LDL by macrophages.

  1980cited by this paper
• Inhibition of receptor-mediated clearance of lysine and arginine-modified lipoproteins from the plasma of rats and monkeys.

  1980cited by this paper
• Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction.

  1979cited by this paper
• Hydroperoxide metabolism in mammalian organs.

  1979cited by this paper
• A sensitive fluorometric method for the determination of arginine using 9,10-phenanthrenequinone.

  1978cited by this paper
• Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

  1978cited by this paper
• Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts.

  1976cited by this paper
• The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations.

  1972cited by this paper
• A rapid method of total lipid extraction and purification.

  1959cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Clearance and Utilization of Dicarbonyl-Modified LDL in Monkeys and Humans

  2023cites this paper
• Dicarbonyl-Modified Low-Density Lipoproteins Are Key Inducers of LOX-1 and NOX1 Gene Expression in the Cultured Human Umbilical Vein Endotheliocytes

  2023cites this paper
• Differences in Structural Changes and Pathophysiological Effects of Low-Density Lipoprotein Particles upon Accumulation of Acylhydroperoxy Derivatives in Their Outer Phospholipid Monolayer or upon Modification of Apoprotein B-100 by Natural Dicarbonyls

  2023cites this paper
• Analysis of Methylglyoxal Concentration in a Group of Patients with Newly Diagnosed Prediabetes

  2023cites this paper
• Differences in structural changes and pathophysiologic effects of low-density lipoproteins upon accumulation of acylhydroperoxy derivatives in their outer phospholipid monolayer or upon chemical modification of apoprotein b-100 by natural dicarbonyl

  2023cites this paper
• Advanced glycation endproducts in diabetes-related macrovascular complications: focus on methylglyoxal.

  2022cites this paper
• Methylglyoxal, a highly reactive dicarbonyl compound, in diabetes, its vascular complications and other age-related diseases.

  2020cites this paper
• Formation and migration of α-dicarbonyl compounds during storage and reheating of a sugary food simulation system.

  2020cites this paper
• The role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases.

  2015cites this paper
• Methylglyoxal and glyoxalase I in atherosclerosis.

  2014cites this paper
• Malonyldialdehyde and glyoxal act differently on low-density lipoproteins and endotheliocytes

  2014cites this paper
• Detection of oxidized and glycated proteins in clinical samples using mass spectrometry--a user's perspective.

  2014cites this paper
• Investigating Changes in the Composition and the Function of High Density Lipoprotein after Roux-n-Y Bariatric Surgery

  2014influential citation
• [The role of oxidative processes in augmentation of atherogenity of low density lipoprotein particles].

  2012cites this paper
• Identification and quantification of α-dicarbonyl compounds produced in different sugar-amino acid Maillard reaction model systems

  2011cites this paper
• Methylglyoxal enhances sodium nitroprusside-induced relaxation in rat aorta.

  2010cites this paper
• Glycation of LDL in non-diabetic people: Small dense LDL is preferentially glycated both in vivo and in vitro.

  2009cites this paper
• Mevastatin increases eNO synthase expression and inhibits lipid peroxidation in human endothelial cells

  2007cites this paper
• Glycation of low‐density lipoprotein results in the time‐dependent accumulation of cholesteryl esters and apolipoprotein B‐100 protein in primary human monocyte‐derived macrophages

  2007cites this paper
• The Roles of Protein Glycation, Glycoxidation, and Advanced Glycation End-Product Formation in Diabetes-Induced Atherosclerosis

  2006cites this paper
• Methylglyoxal administration induces diabetes-like microvascular changes and perturbs the healing process of cutaneous wounds.

  2005cites this paper
• Glycation of low-density lipoproteins by methylglyoxal and glycolaldehyde gives rise to the in vitro formation of lipid-laden cells

  2005cites this paper
• Spectroscopic studies of methylglyoxal in water and dimethylsulfoxide.

  2004cites this paper
• Glycation and glycoxidation of low-density lipoproteins by glucose and low-molecular mass aldehydes. Formation of modified and oxidized particles.

  2003cites this paper
• Novel inhibitors of advanced glycation endproducts.

  2003cites this paper
• Macrophage foam cells and atherosclerosis.

  2001cites this paper
• Evidence that pioglitazone, metformin and pentoxifylline are inhibitors of glycation.

  2000cites this paper
• Novel inhibitors of advanced glycation endproducts (part II).

  2000cites this paper
• Klinische (Bio)chemie en Methodologie

  1999cites this paper
• Novel inhibitors of advanced glycation endproducts.

  1999cites this paper